Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin

Pediatric Blood and Cancer

Volumn 61, Issue 9, 2014, Pages 1685-1689

  Soni, Sandeep ^a   Gross, Thomas G ^a   Rangarajan, Hemalatha ^a   Baker, K Scott ^b   Sturm, Mollie ^a,c   Rhodes, Melissa ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b USA   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Blood and marrow transplant; Sibling donor; Sickle cell disease; Stem cell transplant

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETIRACETAM; FLUCONAZOLE; IMMUNOGLOBULIN G; METHOTREXATE; NARCOTIC AGENT; PENICILLIN DERIVATIVE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHIMERA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; DISEASE SEVERITY; DRUG WITHDRAWAL; ENGRAFTMENT; EPSTEIN BARR VIRUS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION COST; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG DISEASE; LYMPHOCYTE SUBPOPULATION; MALE; MATCHED SIBLING DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLIC SYNDROME X; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; NONHUMAN; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; OVERALL SURVIVAL; PAIN; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SEIZURE; SICKLE CELL ANEMIA; SINGLE DRUG DOSE; THYROID DISEASE; TREATMENT RESPONSE; VIRUS REACTIVATION;

BLOOD AND MARROW TRANSPLANT; SIBLING DONOR; SICKLE CELL DISEASE; STEM CELL TRANSPLANT;

ADOLESCENT; ANEMIA, SICKLE CELL; ANIMALS; ANTILYMPHOCYTE SERUM; BUSULFAN; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES; RABBITS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84904438513     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25059     Document Type: Article

References (21)

1. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335:369-376.
2. Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: The first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22:1-6.
3. Shenoy S. Has stem cell transplantation come of age in the treatment of sickle cell disease? Bone Marrow Transplant 2007; 40:813-821.
4. Walters MC, Patience M, Leisenring W, et al. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions. Biol Blood Marrow Transplant 1997; 3:310-315.
5. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101:2137-2143.
6. Walters MC, Patience M, Leisenring W, et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996; 2:100-104.
7. McPherson ME, Hutcherson D, Olson E, et al. Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. Bone Marrow Transplant 2011; 46:27-33.
8. Majumdar S, Robertson Z, Robinson A, et al. Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience. Bone Marrow Transplant 2010; 45:895-900.
9. Walters MC, Patience M, Leisenring W, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 2001; 7:665-673.
10. Gaber AO, Matas AJ, Henry ML, et al. Antithymocyte globulin induction in living donor renal transplant recipients: Final report of the TAILOR registry. Transplantation 2012; 94:331-337.
11. Byrne JL, Stainer C, Cull G, et al. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia. Bone Marrow Transplant 2000; 25:411-417.
12. Goussetis E, Peristeri I, Kitra V, et al. HLA-matched sibling stem cell transplantation in children with beta-thalassemia with anti-thymocyte globulin as part of the preparative regimen: The Greek experience. Bone Marrow Transplant 2012; 47:1061-1066.
13. Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110:2749-2756.
14. Przepiorka D, Weisdorf D, Martin P, et al. 1994; Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995:825-828.
15. Carreras E, Granena A, Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood Rev 1993; 7:43-51.
16. Kim DH, Sohn SK, Won DI, et al. Rapid helper T-cell recovery above 200×10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37:1119-1128.
17. Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther 2003; 3:1215-1224.
18. Seidel MG, Fritsch G, Matthes-Martin S, et al. Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2005; 27:532-536.
19. Hassan M, Ljungman P, Ringden O, et al. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: Time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant 2000; 25:915-924.
20. Kalpatthi R, Brian L, Woods G, et al. Utilization and outcome of bone marrow transplantation in children with sickle cell disease: A Pediatric Health Information System Database Analysis. Biol Blood Marrow Transplant 2013; 89:S159.
21. Kauf TL, Coates TD, Huazhi L, et al. The cost of health care for children and adults with sickle cell disease. Am J Hematol 2009; 84:323-327.